Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02706912 · ClinicalTrials.gov registry record · NA

Virtual Occupational Therapy Application

A NA study of Stroke and Hemiparesis, sponsored by Barron Associates.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT02706912: Completed NA study of Stroke and Hemiparesis, sponsored by Barron Associates.

NCT02706912 is a NA study of Stroke and Hemiparesis that has completed, run by Barron Associates. The registered enrollment target is 22 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02706912, a NA study of Stroke and Hemiparesis, has completed, sponsored by Barron Associates.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

Virtual Occupational Therapy Application (VOTA) combines low-cost human motion tracking, commercial game engine technology, and evidence-based Occupational Therapy (OT) practice in a computer-based virtual world in which stroke patients practice activities of daily living (ADLs). The protocol investigates the efficacy of VOTA therapy for Upper Extremity (UE) motor recovery and assesses system usability and user acceptance.

Primary Outcome

Measure of upper extremity motor function

Conditions Studied

Interventions

  • BEHAVIORAL VOTA Therapy

Study Locations (1)

Virginia

  • UVA- HealthSouth Rehabilitation Hospital - Charlottesville

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2016-02
Est. Completion 2017-02
Phase NA
Barron Associates

10 total trials

What the finished NCT02706912 record still lists

NCT02706912 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which VOTA Therapy is the first listed.

NCT02706912 reports a single indexed study location in Virginia.

Frequently Asked Questions

What is clinical trial NCT02706912 about?

NCT02706912 is a clinical study titled "Virtual Occupational Therapy Application". Virtual Occupational Therapy Application (VOTA) combines low-cost human motion tracking, commercial game engine technology, and evidence-based Occupational Therapy (OT) practice in a computer-based virtual world in which stroke patients practice activities of daily living (ADLs). The protocol invest...

What is the current status of trial NCT02706912?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-02. Estimated completion is 2017-02.

What conditions does trial NCT02706912 study?

This clinical trial studies the following conditions: Stroke, Hemiparesis.

What interventions are being tested in trial NCT02706912?

The interventions under investigation include: VOTA Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT02706912?

This trial is sponsored by Barron Associates, which has 10 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02706912 being conducted?

This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02706912's enrollment target sits among peer trials

22 352nd of 454 higher than 100 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02706912, the US trial registry maintained by the National Library of Medicine. NCT02706912 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.